Skip to main content
SpringerLink
Log in

Characterization of Cellular Viability Using Label-Free Brightfield Live-Cell Imaging

  • Protocol
  • First Online:
Chemogenomics

Part of the book series: Methods in Molecular Biology ((MIMB,volume 2706))

Abstract

In recent years, the assembly and annotation of chemogenomic libraries have gained interest by the phenotypic screening community. Apart from basic annotations of the compound potency and selectivity, these compound libraries benefit in particular from annotation regarding the effect of the inhibitors on cellular viability to distinguish between on-target effects of a compound and unspecific cytotoxicity. Here, we provide a protocol to determine viability as a first determinant in compound quality control, using the Incucyte live-cell imaging system. The compounds are classified according to their calculated growth rate to determine a cytotoxic, cytostatic, or healthy outcome. All compounds affecting the growth rate can be further evaluated regarding their specific effects on cell health in a high-content live-cell multiplex assay, described in Chapter 5.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Tjaden A, Chaikuad A, Kowarz E, Marschalek R, Knapp S, Schröder M, Müller S (2022) Image based annotation of chemogenomic libraries for phenotypic screening. Molecules 27:1439

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Müller S et al (2022) Target 2035 – update on the quest for a probe for every protein. RSC Med Chem 13:13–21

    Article  PubMed  Google Scholar 

  3. Moffat JG, Vincent F, Lee JA, Eder J, Prunotto M (2017) Opportunities and challenges in phenotypic drug discovery: an industry perspective. Nat Rev Drug Discov 16:531–543

    Article  CAS  PubMed  Google Scholar 

  4. Wagner BK, Schreiber SL (2016) The power of sophisticated phenotypic screening and modern mechanism-of-action methods. Cell Chem Biol 23:3–9

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Hafner J, Niepel M, Chung M, Sorger PK (2016) Growth rate inhibition metrics correct for confounders in measuring sensitivity to cancer drugs. Nat Methods 13:521–527

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Hughes P, Marshall D, Reid Y, Parkes H, Gelber C (2018) The costs of using unauthenticated, over-passaged cell lines: how much more data do we need? BioTechniques 43. https://www.future-science.com/doi/10.2144/000112598

  7. Kozikowski BA et al (2003) The effect of room-temperature storage on the stability of compounds in DMSO. J Biomol Screen 8:205–209

    Article  CAS  PubMed  Google Scholar 

  8. Sartorius (2022) Incucyte live-cell analysis systems user manual. https://www.sartorius.com/download/1087348/incucyte-live-cell-analysis-systems-user-manual-en-l-8000-04-1%2D%2Ddata.pdf. Accessed 17 June 2022

  9. EMBL-EBI (2022) BioImage Archive https://www.ebi.ac.uk/bioimage-archive/. Accessed 4 July 2022

  10. Al-Aamri H et al (2019) Time dependent response of daunorubicin on cytotoxicity, cell cycle and DNA repair in acute lymphoblastic leukaemia. BMC Cancer 19. https://doi.org/10.1186/s12885-019-5377-y

  11. Bruno S et al (1992) Different effects of staurosporine, an inhibitor of protein kinases, on the cell cycle and chromatin structure of normal and leukemic lymphocytes. Cancer Res 51:470–473

    Google Scholar 

  12. Seina J et al (2001) Cytotoxicity of digitoxin and related cardiac glycosides in human tumor cells. Anti-Cancer Drugs 12:475–483

    Article  Google Scholar 

  13. Sanchez-Martinez C, Gelbert LM, Lallena MJ, Dios A (2015) Cyclin dependent kinase (CDK) inhibitors as anticancer drugs. Bioorg Med Chem Lett 25. https://doi.org/10.1016/j.bmcl.2015.05.100

  14. Picaud S et al (2016) Promiscuous targeting of bromodomains by bromosporine identifies BET proteins as master regulators of primary transcription response in leukemia. Sci Adv 2. https://doi.org/10.1126/sciadv.1600760

  15. Wen N et al (2019) Bromodomain inhibitor JQ1 induces cell cycle arrest and apoptosis of glioma stem cells through VEGF/PI3K/AKT signalling pathway. Int J Oncol 55. https://doi.org/10.3892/ijo.2019.4863

  16. Wang TH et al (2000) Paclitaxel-induced cell death. Am Cancer Soc J 88. https://doi.org/10.1002/1097-0142(20000601)88:11<2619::AID-CNCR26>3.0.CO;2-J

  17. Francipane MG, Lagasse E (2013) Selective targeting of human colon cancer stem-like cells by the mTOR inhibitor Torin-1. Oncotarget 4. https://doi.org/10.18632/oncotarget.1310

  18. Violante GA et al (2002) Evaluation of the cytotoxicity effect of dimethyl sulfoxide (DMSO) on CaCo2/TC/colon tumor cell cultures. Biol Pharmaceut Bull 25:1600–1603

    Article  Google Scholar 

Download references

Acknowledgement

The authors are grateful for support by the Structural Genomics Consortium (SGC), a registered charity (No: 1097737) that receives funds from Bayer AG, Boehringer Ingelheim, Bristol Myers Squibb, Genentech, Genome Canada through Ontario Genomics Institute, Janssen, Merck KGaA, Pfizer and Takeda and by the German Cancer Research Center DKTK and the Frankfurt Cancer Institute (FCI). This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875510. The JU receives support from the European Union’s Horizon 2020 research and innovation program and EFPIA and Ontario Institute for Cancer Research, Royal Institution for the Advancement of Learning McGill University, Kungliga Tekniska Hoegskolan, Diamond Light Source Limited. Disclaimer: This communication reflects the views of the authors, and the JU is not liable for any use that may be made of the information contained herein. A.T. is supported by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) – grant number 259130777 (SFB1177). We would also like to thank Dr. Alexandra Stolz and her team for assistance with experimental setup and image optimization.

Author information

Authors and Affiliations

  1. Institute of Pharmaceutical Chemistry, Goethe University Frankfurt, Frankfurt, Germany

    Lewis Elson, Amelie Tjaden, Stefan Knapp & Susanne Müller

  2. Structural Genomics Consortium, BMLS, Goethe University Frankfurt, Frankfurt, Germany

    Lewis Elson, Amelie Tjaden, Stefan Knapp & Susanne Müller

Authors
  1. Lewis Elson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Amelie Tjaden
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Stefan Knapp
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Susanne Müller
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Susanne Müller .

Editor information

Editors and Affiliations

  1. Department of Pharmacy, Ludwig-Maximilians-Universität München, Munich, Germany

    Daniel Merk

  2. Institute of Pharmaceutical Chemistry, Goethe University Frankfurt, Frankfurt am Main, Germany

    Apirat Chaikuad

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature

About this protocol

Check for updates. Verify currency and authenticity via CrossMark

Cite this protocol

Elson, L., Tjaden, A., Knapp, S., Müller, S. (2023). Characterization of Cellular Viability Using Label-Free Brightfield Live-Cell Imaging. In: Merk, D., Chaikuad, A. (eds) Chemogenomics. Methods in Molecular Biology, vol 2706. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-3397-7_6

Download citation

  • DOI: https://doi.org/10.1007/978-1-0716-3397-7_6

  • Published:

  • Publisher Name: Humana, New York, NY

  • Print ISBN: 978-1-0716-3396-0

  • Online ISBN: 978-1-0716-3397-7

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics

Search

Navigation